Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101,960,784
-
Total 13F shares
-
76,570,666
-
Share change
-
-4,213,219
-
Total reported value
-
$1,117,957,204
-
Put/Call ratio
-
181%
-
Price per share
-
$14.60
-
Number of holders
-
138
-
Value change
-
-$50,224,829
-
Number of buys
-
71
-
Number of sells
-
49
Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q4 2023
As of 31 Dec 2023,
Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
76,570,666 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Atlas Venture Life Science Advisors, LLC, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BRAIDWELL LP, FMR LLC, STATE STREET CORP, Pictet Asset Management Holding SA, and VIKING GLOBAL INVESTORS LP.
This page lists
138
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.